CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-01 | FitzPatrick Margaret M Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-03-01 | SAXE JON S Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-03-01 | Rotunno Mary L. Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-03-01 | Curley Joanne Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-01-11 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Option exercise | +18,750 | $1.00 | $19K | 94,571 |
| 2022-01-11 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Option exercise · Stock Option (Right to Buy) | −18,750 | 15,625 | ||
| 2021-12-31 | Smith Mark Alan CHIEF MEDICAL OFFICER | Grant or award | +2,655 | $1.66 | $4K | 14,915 |
| 2021-12-31 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Grant or award | +3,575 | $1.66 | $6K | 75,821 |
| 2021-12-31 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Grant or award | +3,623 | $1.66 | $6K | 64,958 |
| 2021-12-31 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award | +3,623 | $1.66 | $6K | 48,998 |
| 2021-09-07 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Sale | −30,000 | $3.13 | $94K | 72,786 |
| 2021-09-02 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Gift | +1,111 | 61,335 | ||
| 2021-08-23 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Gift | −740 | 33,901 | ||
| 2021-08-17 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Purchase | +3,750 | $2.73 | $10K | 34,641 |
| 2021-07-21 | FitzPatrick Margaret M Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2021-07-06 | Rotunno Mary L. Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2021-06-30 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Grant or award | +3,044 | $1.95 | $6K | 13,044 |
| 2021-06-30 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Option exercise | +1,000 | $1.50 | $2K | 14,044 |
| 2021-06-30 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Option exercise | +78,918 | $1.00 | $79K | 92,962 |
| 2021-06-30 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Option exercise | +9,824 | $0.40 | $4K | 102,786 |
Page 5 of 17 · 323 trades